Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Moderna

Turkey reports daily record of 111,157 new cases – as it happened

Turkish daily death toll highest in four months as cases surge; UK health agency says number of cases each day could be rising

The Guardian - AU

Coronavirus live: Europe in virus ‘ceasefire’ with tranquil period ahead, says WHO; record UK long Covid cases — as it happened

Europe could enter ‘long period of Covid tranquility’ due to high vaccination rates, WHO says; record 1.33 million UK long Covid patients

The Guardian - AU

Covid rules on travelling to different countries around Europe

Here's everything you need to know about vaccination status and testing process in countries such as France, Austria, Switzerland and Italy

Wales Online

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna Whale Trades For February 02

A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 10 strange trades.

Benzinga

Study confirms effectiveness of COVID-19 booster vaccinations

A new study from the Center for Disease Control and Prevention confirms what Mayo Clinic and other experts have been saying: COVID-19 booster vaccinations improve protection against severe illness and hospitalization. The study examined people who had three doses of the Moderna or Pfizer COVID-19 vaccines, as well as whether…

Tribune News Service

Moderna gains full FDA approval for COVID-19 vaccine while Novavax makes push for its own shot

WASHINGTON — Moderna Inc.’s vaccine for COVID-19 received full approval from the U.S. Food and Drug Administration for people 18 and older, an important milestone that bolsters the shot’s use as a major weapon against the virus.

Tribune News Service

Why Moderna Shares Are Rising Today

Moderna Inc (NASDAQ: MRNA) is trading higher Monday after the U.S. Food and Drug Administration approved the Biologics License Application for SPIKEVAX to prevent COVID-19 in individuals 18 years of age and older.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Moderna's COVID-19 Vaccine Becomes Second To Score Complete FDA Approval

The FDA has given complete approval to Moderna Inc's (NASDAQ:

Benzinga

FDA fully approves Moderna's COVID vaccine

Moderna's vaccine will now be marketed as Spikevax.

Axios

Moderna announces full US approval for its COVID-19 vaccine

Moderna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness

The Independent UK

Moderna Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.

Benzinga

Covid news: UK health secretary says mandatory vaccination for NHS workers ‘no longer proportionate’ – as it happened

Sajid Javid says says mandatory jabs were ‘right policy at the time’ but announces review

The Guardian - AU

An HIV vaccine is finally on its way

The same mRNA technology that’s helping us fight COVID provided a formula that’s evaded scientists for 40 years.

Mic

The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

After Pfizer, Moderna Kickstarts Omicron-Targeted COVID-19 Vaccine Trial

Moderna Inc (NASDAQ: MRNA) has started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically

Asharq Al-Awsat

Moderna Begins Trial of Omicron-specific Vaccine Booster

US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.

The Guardian - UK

Boosters increase protection against death from Omicron in over-50s to 95% – UKHSA; UK records 338 deaths – as it happened

Protection against death increases to around 95% two weeks after receiving a booster dose, UK health agency says; UK reports another 96,871 Covid cases

The Independent UK

Moderna begins testing omicron-matched COVID shots in adults

Moderna has begun testing an omicron-specific version of its COVID-19 vaccine in healthy adults

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Moderna Shares Are Rising

Moderna Inc (NASDAQ: MRNA) shares are trading higher by 7.2% at $163.54 Wednesday afternoon after Deutsche Bank upgraded the stock from Sell to Hold and announced a $175 price target.

StockNews.com

Down Close to 40% Year-To-Date, Now is a Good Time to Scoop Up Moderna and BioNTech

The ongoing market correction has caused the shares of popular vaccine makers Moderna (MRNA) and BioNTech (BNTX) to decline nearly 40% in price so far this year. However, because the demand for COVID-19 vaccines remains strong globally, these companies are expected to generate substantial revenues and profits in the coming…

The Guardian - AU

UK reports 346 daily deaths; Denmark aims to end all restrictions – as it happened

UK also records over 102,000 daily cases; Danish plan would mean most far-reaching easing among Nordic countries

Daily Record

NHS Lanarkshire now administering Moderna jab as part of vaccination programme

The health board confirmed the plans as the booster programmes continues across Lanarkshire.

Benzinga

This Is What Whales Are Betting On Moderna

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

5 Stocks Insiders Are Selling: Alphabet, Moderna And More

Crude oil futures dipped more than 2% on Monday as the US dollar strengthened following increasing concerns between the US and Russia over Ukraine. Investors, meanwhile, focused on some notable insider trades.

The Conversation

How mRNA and DNA vaccines could soon treat cancers, HIV, autoimmune disorders and genetic diseases

The two most successful coronavirus vaccines developed in the U.S. – the Pfizer and Moderna vaccines – are both mRNA vaccines. The idea of using genetic material to produce an immune response has opened up a world of research and potential medical uses far out of reach of traditional vaccines.…

1 … 31 32 33 34

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.